281 related articles for article (PubMed ID: 30742691)
1. Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.
Trobaugh DW; Sun C; Dunn MD; Reed DS; Klimstra WB
PLoS Pathog; 2019 Feb; 15(2):e1007584. PubMed ID: 30742691
[TBL] [Abstract][Full Text] [Related]
2. Hypervariable Domain of nsP3 of Eastern Equine Encephalitis Virus Is a Critical Determinant of Viral Virulence.
Meshram CD; Shiliaev N; Frolova EI; Frolov I
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581106
[TBL] [Abstract][Full Text] [Related]
3. A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation.
Pandya J; Gorchakov R; Wang E; Leal G; Weaver SC
Vaccine; 2012 Feb; 30(7):1276-82. PubMed ID: 22222869
[TBL] [Abstract][Full Text] [Related]
4. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice.
Wang E; Petrakova O; Adams AP; Aguilar PV; Kang W; Paessler S; Volk SM; Frolov I; Weaver SC
Vaccine; 2007 Oct; 25(43):7573-81. PubMed ID: 17904699
[TBL] [Abstract][Full Text] [Related]
7. Cooperativity between the 3' untranslated region microRNA binding sites is critical for the virulence of eastern equine encephalitis virus.
Trobaugh DW; Sun C; Bhalla N; Gardner CL; Dunn MD; Klimstra WB
PLoS Pathog; 2019 Oct; 15(10):e1007867. PubMed ID: 31658290
[TBL] [Abstract][Full Text] [Related]
8. Polymerase Mechanism-Based Method of Viral Attenuation.
Lee CA; August A; Arnold JJ; Cameron CE
Methods Mol Biol; 2016; 1349():83-104. PubMed ID: 26458831
[TBL] [Abstract][Full Text] [Related]
9. Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.
Aguilar PV; Adams AP; Wang E; Kang W; Carrara AS; Anishchenko M; Frolov I; Weaver SC
J Virol; 2008 May; 82(10):4920-30. PubMed ID: 18353963
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence.
Gardner CL; Ebel GD; Ryman KD; Klimstra WB
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16026-31. PubMed ID: 21896745
[TBL] [Abstract][Full Text] [Related]
11. Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge.
Honnold SP; Bakken RR; Fisher D; Lind CM; Cohen JW; Eccleston LT; Spurgers KB; Maheshwari RK; Glass PJ
PLoS One; 2014; 9(8):e104708. PubMed ID: 25116127
[TBL] [Abstract][Full Text] [Related]
12. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
[TBL] [Abstract][Full Text] [Related]
13. Designing multivalent immunogens for alphavirus vaccine optimization.
Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
[TBL] [Abstract][Full Text] [Related]
14. A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.
Roy CJ; Adams AP; Wang E; Leal G; Seymour RL; Sivasubramani SK; Mega W; Frolov I; Didier PJ; Weaver SC
Vaccine; 2013 Mar; 31(11):1464-70. PubMed ID: 23333212
[TBL] [Abstract][Full Text] [Related]
15. Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates.
Schoepp RJ; Smith JF; Parker MD
Virology; 2002 Oct; 302(2):299-309. PubMed ID: 12441074
[TBL] [Abstract][Full Text] [Related]
16. Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection.
Williamson LE; Gilliland T; Yadav PK; Binshtein E; Bombardi R; Kose N; Nargi RS; Sutton RE; Durie CL; Armstrong E; Carnahan RH; Walker LM; Kim AS; Fox JM; Diamond MS; Ohi MD; Klimstra WB; Crowe JE
Cell; 2020 Dec; 183(7):1884-1900.e23. PubMed ID: 33301709
[TBL] [Abstract][Full Text] [Related]
17. Use of sindbis/eastern equine encephalitis chimeric viruses in plaque reduction neutralization tests for arboviral disease diagnostics.
Johnson BW; Kosoy O; Wang E; Delorey M; Russell B; Bowen RA; Weaver SC
Clin Vaccine Immunol; 2011 Sep; 18(9):1486-91. PubMed ID: 21752946
[TBL] [Abstract][Full Text] [Related]
18. Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice.
Gardner CL; Yin J; Burke CW; Klimstra WB; Ryman KD
Virology; 2009 Aug; 390(2):338-47. PubMed ID: 19539968
[TBL] [Abstract][Full Text] [Related]
19. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
20. Attenuation and immunogenicity of ts mutants of Eastern encephalitis virus for mice.
Brown A; Vosdingh R; Zebovitz E
J Gen Virol; 1975 Apr; 27(1):111-6. PubMed ID: 49393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
